Neuro-Immune Axis in Trauma-Induced Heterotopic Ossification: Mechanisms and Therapeutic Implications
Cells · 2026
DOI: 10.3390/cells15090827 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Oluomachukwu Jennifer Agu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California Davis Medical Center, Sacramento, CA 95817, USA. Hauptthemen laut MEDLINE: Ossification, Heterotopic, Wounds and Injuries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIH/ National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Trauma-induced heterotopic ossification (tHO) is characterized by aberrant ectopic bone formation in soft tissue following high-energy trauma, affecting >60% of combat-related amputees and >50% of major burn patients. Current prophylactic strategies (including NSAIDs, bisphosphonates, and low-dose radiation) lack mechanistic specificity, carry significant side effects, and surgical excision carries a 27% recurrence rate. This review reframes tHO pathogenesis through the neural–immune axis, arguing that ectopic bone formation is a downstream consequence of dysregulated neuroimmune signaling rather than a primary osteogenic event. Following trauma, nociceptor activation drives nociception-induced neural inflammation (NINI), releasing substance P (SP) and calcitonin gene-related peptide (CGRP), which disrupts the blood–nerve barrier, mobilizes neural crest-derived progenitor cells, and, alongside BMP-2/SMAD1/5/8 signaling and M1-polarized macrophage activation, establishes a permissive osteogenic microenvironment. A BMP-2/CGRP positive feedback loop sustains aberrant osteogenesis, converging on osteogenic transcription factors Runx2, SOX5/6/9, and Osterix. Dysregulated noncoding RNAs represent promising pre-radiographic biomarkers. This neural–immune framework motivates mechanism-based therapeutic strategies targeting CGRP (fremanezumab, erenumab), SP/NK1 signaling (aprepitant), and macrophage polarization (metformin, palovarotene, rapamycin), with multi-node combination approaches tailored to the temporal stages of tHO offering the most promise for precision prophylaxis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of California Davis Medical Center, Sacramento, CA 95817, USA.
ORCID-Profile: Ishaan Gupta, Tahmineh Mokhtari
Förderung
- NIAMS NIH HHS
- NIH/ National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Agu, O. J., Pereira, C., Gupta, I., Moran, A., & Mokhtari, T. (2026). Neuro-Immune Axis in Trauma-Induced Heterotopic Ossification: Mechanisms and Therapeutic Implications. Cells. https://doi.org/10.3390/cells15090827
Vancouver
Agu OJ, Pereira C, Gupta I, Moran A, Mokhtari T. Neuro-Immune Axis in Trauma-Induced Heterotopic Ossification: Mechanisms and Therapeutic Implications. Cells. 2026. doi:10.3390/cells15090827
BibTeX
@article{Agu2026,
author = {Agu, Oluomachukwu Jennifer and Pereira, Clifford and Gupta, Ishaan and Moran, Ashley and Mokhtari, Tahmineh},
title = {Neuro-Immune Axis in Trauma-Induced Heterotopic Ossification: Mechanisms and Therapeutic Implications},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15090827}
}
EUVIMED